Does Blue Cross Blue Shield of Arizona Cover Viagra?

The Short Answer on BCBSAZ and Viagra Coverage

Blue Cross Blue Shield of Arizona does not guarantee Viagra coverage across all plans, but many BCBSAZ members do have access to sildenafil through their pharmacy benefit. The determining factors are your plan type (PPO, HMO, or employer-sponsored), the specific formulary your plan uses, and whether prior authorization has been completed. Generic sildenafil, which entered the U.S. Market in December 2017 after Pfizer's patent expired, costs dramatically less than brand-name Viagra and appears on more BCBSAZ formularies.

Erectile dysfunction (ED) affects an estimated 30 million men in the United States, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). That prevalence has pushed payers, including BCBSAZ, to reevaluate formulary placement of phosphodiesterase type 5 (PDE5) inhibitors over the past several years.

Why Coverage Varies So Much

BCBSAZ administers dozens of distinct plan designs for individual, family, and employer group markets. Each plan contracts a specific drug formulary. One employer's BCBSAZ PPO may place generic sildenafil on Tier 2 with a $20 copay, while an ACA marketplace plan from the same insurer may exclude it entirely or place it on a non-preferred Tier 3 or 4 with a $70 copay.

The Affordable Care Act does not classify ED medications as essential health benefits, so insurers are not required to cover them. That gap in federal law is why coverage is inconsistent across plans.

How to Find Out Whether Your Plan Covers Sildenafil

The fastest method is to log into your BCBSAZ member portal at azblue.com and use the drug lookup tool under "Pharmacy Benefits." Enter "sildenafil" (the generic name) rather than "Viagra" to capture all formulary entries. Alternatively, call BCBSAZ member services at 1-800-232-2345 with your member ID and ask a representative to confirm:

1. Whether sildenafil citrate (any strength) is on your formulary.
2. The tier placement and associated copay or coinsurance.
3. Whether prior authorization is required.
4. Any quantity limits (typically 6 or 8 tablets per 30-day supply for ED indications).

Formulary Tiers and What They Mean for Your Out-of-Pocket Cost

BCBSAZ plans generally use a 3- to 5-tier formulary structure. Where sildenafil lands determines what you pay.

Tier 1 and Tier 2 Placement

Generic drugs, including generic sildenafil, most often land on Tier 1 (preferred generic) or Tier 2 (non-preferred generic or preferred brand). At Tier 1, your copay may be as low as $5, $15 per fill on a 30-day supply. At Tier 2, expect $20, $50. These figures vary by plan and deductible status.

Tier 3 and Non-Preferred Tiers

Brand-name Viagra, if covered at all, typically sits at Tier 3 or higher. Coinsurance at these tiers commonly runs 40 to 50% of the negotiated drug price. Given that brand Viagra's average wholesale price can exceed $500 for a 30-tablet supply, even 40% coinsurance means paying $200+ per fill. Most physicians and pharmacists will steer patients toward generic sildenafil for this reason.

Drugs Excluded from the Formulary

Some BCBSAZ plans place all ED medications on an exclusion list, meaning no coverage regardless of tier. If your plan excludes sildenafil, you have four realistic options: (1) appeal with a medical necessity letter from your physician, (2) ask HR whether your employer plan has an exception process, (3) use a GoodRx or similar discount card that bypasses insurance entirely, or (4) explore a telehealth cash-pay service where generic sildenafil may cost $1, $3 per tablet.

Prior Authorization for Viagra and Sildenafil Under BCBSAZ

Prior authorization (PA) is a formal approval process BCBSAZ uses to confirm that a medication is medically necessary before agreeing to pay for it. For ED medications, PA is common even when sildenafil appears on the formulary.

What Triggers a Prior Authorization Request

Your pharmacy will alert you at pickup if PA is required. Your physician's office then submits clinical documentation to BCBSAZ. Typical requirements include:

• A confirmed diagnosis of erectile dysfunction (ICD-10 code N52.x) or pulmonary arterial hypertension (PAH, ICD-10 I27.0).
• Documentation of any underlying conditions contributing to ED, such as type 2 diabetes or cardiovascular disease.
• A statement that the prescribing physician has evaluated cardiovascular risk, which is clinically relevant because PDE5 inhibitors are contraindicated with nitrate medications. The FDA prescribing information for sildenafil specifically warns against concurrent nitrate use due to risk of severe hypotension (FDA).

How Long Prior Authorization Takes

Standard PA decisions typically arrive within 1 to 3 business days. Urgent PA requests, when a physician certifies clinical urgency, must be resolved within 72 hours under Arizona Department of Insurance regulations. If BCBSAZ denies the PA, you have the right to an internal appeal and, if that fails, an external independent review.

Tips for a Successful PA Submission

Your physician's office can improve the approval rate by submitting detailed chart notes that document:

• Duration and severity of ED symptoms.
• Prior treatments tried, if any.
• Comorbidities such as hypertension, diabetes, or hypogonadism that contribute to ED.
• Absence of contraindications (no concurrent nitrate use, no severe hepatic impairment).

Research published in the Journal of Sexual Medicine found that men with comorbid diabetes and ED had significantly higher rates of PA approval for PDE5 inhibitors compared with men whose ED had no documented organic cause (PubMed).

Generic Sildenafil vs. Brand-Name Viagra: The Clinical and Cost Case

Pfizer's Viagra (sildenafil citrate) received FDA approval in March 1998 as the first oral PDE5 inhibitor for erectile dysfunction (FDA). The active molecule is identical in the brand and all FDA-approved generics. The FDA requires generic manufacturers to demonstrate bioequivalence, meaning the generic delivers the same amount of drug to the bloodstream within the same time frame.

Clinical Equivalence

A 2018 systematic review in the Cochrane Database covering 82 randomized controlled trials (N = 11,372 participants) found that sildenafil significantly improved erectile function scores compared with placebo across all doses studied (25 mg, 50 mg, 100 mg), with an International Index of Erectile Function domain score improvement averaging 6.4 points over placebo (Cochrane). That evidence applies equally to generic sildenafil because the molecule is the same.

The Cost Difference Is Dramatic

Before generic entry, a single 100 mg Viagra tablet retailed for roughly $60, $80. By 2023, generic sildenafil 100 mg tablets were available at major pharmacy chains for as little as $1, $3 per tablet with discount programs. Paying cash for generic sildenafil through a GoodRx card will often cost less than your BCBSAZ copay for a brand-name drug, so always compare both options at your pharmacy.

Dosing Reference

Standard sildenafil doses for ED are 25 mg, 50 mg, and 100 mg taken approximately 30 to 60 minutes before sexual activity. The 50 mg dose is the usual starting point for most adults without renal or hepatic impairment. BCBSAZ quantity limits for ED indications are typically 6 to 8 tablets per 30-day fill; confirm the exact limit on your plan's benefit summary.

Pulmonary Arterial Hypertension: A Different Coverage Path

Sildenafil is also FDA-approved under the brand name Revatio (20 mg tablets or oral suspension) for pulmonary arterial hypertension (PAH). This indication carries a different ICD-10 code (I27.0) and is far more likely to be covered by BCBSAZ with fewer restrictions, because PAH is a life-threatening condition with no coverage exemption under most plan designs.

If a physician prescribes sildenafil 20 mg three times daily for PAH, BCBSAZ typically processes that claim under the PAH benefit rather than the ED benefit, which may bypass ED-specific exclusions entirely. Prescribing sildenafil at PAH doses for an ED diagnosis would be clinically inappropriate and constitutes off-label use that insurers routinely flag.

Other PDE5 Inhibitors: Does BCBSAZ Cover Tadalafil (Cialis) or Avanafil (Stendra)?

Sildenafil is not the only option. BCBSAZ formularies may also list:

• Tadalafil (generic Cialis): Available as a 5 mg daily dose or 10 mg/20 mg as-needed. Generic tadalafil entered the U.S. Market in 2018. Its longer half-life (17.5 hours vs. Sildenafil's 3 to 5 hours) suits men who prefer spontaneous rather than planned activity. The 5 mg daily dose also carries an FDA approval for benign prostatic hyperplasia (BPH), which may make coverage easier to obtain for men with both conditions.
• Vardenafil (generic Levitra): Generic available since 2018. Pharmacokinetics similar to sildenafil. Less commonly stocked at retail pharmacies.
• Avanafil (Stendra): Approved in 2012. No generic as of early 2025. Faster onset (approximately 15 minutes) but higher cost and less likely to appear on preferred formulary tiers.

When your BCBSAZ plan excludes brand-name Viagra, checking whether generic tadalafil or generic vardenafil appear at a lower tier is a practical second step before abandoning insurance coverage altogether.

How Testosterone Deficiency Connects to ED Coverage

Low testosterone (hypogonadism) is a documented contributor to erectile dysfunction. Research published in the Journal of Clinical Endocrinology and Metabolism confirmed that testosterone replacement therapy (TRT) in hypogonadal men improved erectile function scores independently of PDE5 inhibitor use (PubMed). When a BCBSAZ member has both a confirmed hypogonadism diagnosis and ED, the medical chart is stronger for PA purposes, and the physician may document both conditions to support the necessity of sildenafil.

BCBSAZ covers FDA-approved testosterone formulations (gels, injections, patches) under different benefit categories, typically the medical benefit rather than the pharmacy benefit for injectables. A urologist or endocrinologist managing both conditions can coordinate the prior authorization submissions for TRT and sildenafil simultaneously, potentially streamlining the approval process.

What to Do If BCBSAZ Denies Your Viagra or Sildenafil Claim

Denial does not mean the decision is final. The appeals process has defined steps under Arizona law and federal ACA regulations.

Step 1: Internal Appeal

You have 180 days from the denial notice to file an internal appeal. Submit a letter from your physician explaining the medical necessity, relevant chart notes, and any published clinical guidelines supporting sildenafil use. The American Urological Association (AUA) 2018 Guideline on Erectile Dysfunction states: "Phosphodiesterase type 5 inhibitors are the first-line treatment for erectile dysfunction in appropriately selected patients." (AUA / PubMed) That language from a named guideline document carries weight in an appeal.

Step 2: External Independent Review

If the internal appeal fails, Arizona law entitles you to an external independent review by a third party not affiliated with BCBSAZ. The Arizona Department of Insurance oversees this process. External reviewers overturn insurer decisions in a meaningful proportion of cases, particularly when the denied drug has strong guideline support.

Step 3: Exceptions and Cost-Sharing Assistance

While appeals proceed, ask your physician about:

• Pfizer's patient assistance program for Viagra (for low-income patients who qualify).
• GoodRx Gold membership, which can reduce generic sildenafil to under $20 for a 30-count supply at participating pharmacies.
• Mark Cuban's Cost Plus Drugs (costplusdrugs.com) offers generic sildenafil 100 mg for approximately $1.00 per tablet as of 2024, cash-pay only.
• HealthRX telehealth consultations, where licensed Arizona physicians can evaluate you and prescribe generic sildenafil at transparent cash-pay pricing without insurance involvement.

Cardiovascular Safety: What BCBSAZ and Your Doctor Both Want Confirmed

Insurance prior authorization forms often mirror clinical safety checklists. BCBSAZ PA forms for sildenafil typically ask whether the patient uses any form of nitrate medication (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrite). The combination of a PDE5 inhibitor and a nitrate can cause a precipitous drop in blood pressure, a potentially life-threatening interaction the FDA highlighted in its original 1998 approval labeling and reaffirmed in subsequent label updates (FDA).

The Princeton Consensus Panel (Third Princeton Consensus, 2012) stratified men with ED into low, intermediate, and high cardiovascular risk categories to guide prescribing decisions (PubMed). Men in the low-risk category, those with controlled hypertension, mild stable angina, or up to two cardiac risk factors but no symptoms, can generally start sildenafil safely. Men at intermediate or high risk require cardiology clearance before PDE5 inhibitor therapy.

Your BCBSAZ prior authorization is more likely to be approved quickly when your physician's submission documents that this cardiovascular risk stratification has been completed.

A Practical Step-by-Step Checklist for BCBSAZ Members Seeking Sildenafil Coverage

1. Log into azblue.com and search the drug formulary for "sildenafil citrate."
2. Note the tier, copay, and any PA requirement shown.
3. Schedule an appointment with a licensed physician or telehealth provider to confirm the ED diagnosis and obtain a prescription.
4. Ask the prescribing physician to submit a PA request with ICD-10 code N52.9 (or the appropriate N52 subcode) and supporting chart notes.
5. Compare your BCBSAZ copay against GoodRx pricing at your preferred pharmacy before filling.
6. If denied, request the specific denial reason in writing and initiate an internal appeal within 180 days.
7. If the appeal fails, file for external independent review through the Arizona Department of Insurance.